THURSDAY, Dec. 27, 2018 — Universal vaccination against Neisseria meningitidis serogroup B (MenB) at college entry does not appear to be cost-effective, according to a study published online Dec. 17 in the American Journal of Preventive Medicine. Ira L. Leeds, M.D., from Johns Hopkins University in Baltimore, and colleagues estimated the costs and benefits of […]
Home »
Cost-effective universal screening for hepatitis C in France
An estimated 75,000 people in France are unaware they are infected by hepatitis C virus. An ANRS-funded study by Sylvie Deuffic-Burban, Ph.D., a research associate at IAME (Infection, Antimicrobials, Modeling, Evolution) (Inserm—Université Paris Diderot—Université Paris 13), and her team show that a universal screening strategy applied to hepatitis C is cost-effective and improves life expectancy […]